Doubling Down: Jurickson Profar Draws a Second PED Suspension, and Johan Rojas (Likely) a First

In 2024, 11 years after he was the consensus no. 1 prospect in the game, Jurickson Profar finally broke out, setting career highs in home runs (24), wRC+ (139) and WAR (4.3), making his first All-Star team, and helping the Padres to an NL Wild Card berth. He cashed in that winter; after never making more than $7.75 million in a season, Profar signed a three-year, $42 million deal with the Braves. Four games into his tenure with his new team, however, he drew an 80-game suspension for violating the Joint Drug Agreement. While he was productive upon returning and figured prominently in the plans of a team expected to contend for the NL East title this season, on Tuesday, the 33-year-old outfielder drew a second PED suspension, this one for the entire 2026 season.
Profar wasn’t the only player reported to be facing a PED suspension on Tuesday, or even the only NL East outfielder who had run afoul of the game’s drug policy. According to multiple sources, the Phillies’ Johan Rojas has an 80-game suspension looming for a first-time offense. While MLB officially announced Profar’s suspension in a press release sent at 6:47 p.m. ET on Tuesday — over six hours after ESPN’s Jeff Passan first broke the news — Rojas’ is not yet official.
Both players are reportedly appealing their suspensions. An hour after Passan’s tweet, The Athletic’s Ken Rosenthal reported that the Major League Baseball Players Association is filing a grievance on Profar’s behalf. It’s not clear yet on what grounds the union is challenging the suspension, but such a case would be heard by MLB’s independent arbitrator, Martin F. Scheinman. Later that afternoon, The Athletic’s Charlotte Varnes and Matt Gelb reported that Rojas is appealing his suspension, as well. He is starting in center field and batting seventh in Philadelphia’s exhibition game on Wednesday against Team Canada. Read the rest of this entry »






